tyrosine and su 11248

tyrosine has been researched along with su 11248 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Morimoto, J; Otsuki, Y; Shibata, MA; Tanaka, Y1
Pfister, C; Pfrommer, H; Roser, F; Tatagiba, MS1
Avril, N; Hoimes, C; Hu, L; Lee, Z; Muzic, R; Sher, A; Valls, L1
Çelik, S; Demir, MK; Kılıc, T; Moujawaz, R; Öven, BB; Somay, A1
Dembélé, P; Garnier, O; Martin, DK; Vilgrain, I1
Arranz Arija, JÁ; Gallardo Díaz, E; González-Del-Alba, A; Lainez-Milagro, N; Lambea Sorrosal, J; Lázaro Quintela, M; Méndez-Vidal, MJ; Peláez Fernández, I; Perez-Valderrama, B; Suárez Rodriguez, C1

Reviews

1 review(s) available for tyrosine and su 11248

ArticleYear
Isolated Pituitary Metastasis of Renal Cell Carcinoma: A Case Report and Systematic Review of the Literature.
    Current medical imaging, 2022, Volume: 18, Issue:13

    Topics: Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Middle Aged; Pituitary Neoplasms; Sunitinib; Tyrosine

2022

Other Studies

5 other study(ies) available for tyrosine and su 11248

ArticleYear
Sunitinib suppresses tumor growth and metastases in a highly metastatic mouse mammary cancer model.
    Anticancer research, 2011, Volume: 31, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Blotting, Western; Body Weight; Female; Humans; Immunoenzyme Techniques; Indoles; Lymphatic Metastasis; Lymphatic Vessels; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Phosphorylation; Pyrroles; Sunitinib; Tumor Cells, Cultured; Tyrosine; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2011
Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro.
    British journal of cancer, 2012, Nov-06, Volume: 107, Issue:10

    Topics: Angiogenic Proteins; Cell Proliferation; Humans; Indoles; Meningeal Neoplasms; Meningioma; Neovascularization, Pathologic; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-sis; Pyrroles; Quinazolines; Receptor, Platelet-Derived Growth Factor beta; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sunitinib; Tumor Cells, Cultured; Tyrosine; Vascular Endothelial Growth Factor A; Xanthones

2012
Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.
    Seminars in roentgenology, 2014, Volume: 49, Issue:3

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium DTPA; Humans; Image Enhancement; Indoles; Kidney Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrroles; Radiopharmaceuticals; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine

2014
Microtumor Spheroids Provide a Model for Studying Molecules Involved in Vascular Organization: An Illustrative Study for VE-cadherin.
    Anticancer research, 2022, Volume: 42, Issue:10

    Topics: Animals; Antigens, CD; Cadherins; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Neovascularization, Pathologic; Phosphorylation; Phosphotyrosine; Sunitinib; Tyrosine

2022
SEOM SOGUG clinical guideline for treatment of kidney cancer (2022).
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023, Volume: 25, Issue:9

    Topics: Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Nivolumab; Quality of Life; Sunitinib; Tyrosine

2023